What is Insys Therapeutics Inc. in the Epstein files?

Insys Therapeutics appears in the documents in relation to news articles and legal proceedings concerning the company's role in the opioid crisis, including allegations of bribery and kickbacks related to the marketing of its fentanyl spray, Subsys. There is no indication of a direct connection between Insys Therapeutics and Jeffrey Epstein within the provided documents, though they share 4 documents.

Why did Insys Therapeutics file for bankruptcy?

Insys Therapeutics filed for bankruptcy in 2019 due to extensive litigation and declining revenues related to its Subsys product, as well as a $225 million settlement with the U.S. Justice Department over its marketing practices.

What was Subsys and what was it used for?

Subsys was a sublingual fentanyl spray manufactured by Insys Therapeutics, approved by the FDA for the treatment of persistent breakthrough pain in adult cancer patients already receiving and tolerant to around-the-clock opioid therapy. However, Insys was found to have improperly marketed and sold Subsys for off-label uses, contributing to the opioid crisis.

What is Insys Therapeutics Inc. in the Epstein files?

Insys Therapeutics appears in the documents in relation to news articles and legal proceedings concerning the company's role in the opioid crisis, including allegations of bribery and kickbacks related to the marketing of its fentanyl spray, Subsys. There is no indication of a direct connection between Insys Therapeutics and Jeffrey Epstein within the provided documents, though they share 4 documents.

Why did Insys Therapeutics file for bankruptcy?

Insys Therapeutics filed for bankruptcy in 2019 due to extensive litigation and declining revenues related to its Subsys product, as well as a $225 million settlement with the U.S. Justice Department over its marketing practices.

What was Subsys and what was it used for?

Subsys was a sublingual fentanyl spray manufactured by Insys Therapeutics, approved by the FDA for the treatment of persistent breakthrough pain in adult cancer patients already receiving and tolerant to around-the-clock opioid therapy. However, Insys was found to have improperly marketed and sold Subsys for off-label uses, contributing to the opioid crisis.

Back to People & Entities

Insys Therapeutics Inc.

Organization

Total Mentions

Documents

149

Connected Entities

Insys Therapeutics Inc. was an American pharmaceutical company that manufactured Subsys, a sublingual fentanyl spray, and faced legal scrutiny and bankruptcy due to its marketing practices and role in the opioid crisis. The company and its executives were found guilty of bribing doctors to prescribe Subsys, leading to a Department of Justice settlement, a bankruptcy filing, and criminal convictions.

Insys Therapeutics appears in the documents primarily in the context of legal and financial proceedings related to its role in the opioid crisis. Mentions include news articles about the company's indictment, the sentencing of its executives for kickbacks, and its bankruptcy proceedings. The documents also reference the company's agreement to pay settlements to resolve criminal and civil investigations.

Key Highlights

•Insys Therapeutics and its executives were convicted of bribing doctors to prescribe Subsys, a fentanyl-based pain medication.
•The company reached a settlement with the Department of Justice over its marketing practices.
•Insys filed for bankruptcy in 2019 due to opioid-related liabilities.

Frequently Asked Questions

Books for Further Reading

Perversion of Justice: The Jeffrey Epstein Story

Julie K. Brown

Investigative journalism that broke the Epstein case open

Filthy Rich: The Jeffrey Epstein Story

James Patterson

Bestselling account of Epstein's crimes and network

Relentless Pursuit: My Fight for the Victims of Jeffrey Epstein

Bradley J. Edwards

Victims' attorney's firsthand account

Document Mentions (6)

EFTA00019088 - EFTA00019091

1 mention

lifornia Steelcase Inc. EFTA00019089 --- PAGE BREAK --- HEALTH Insys Brass Knew Opioid Scripts Were Bogus, 1st Circ. Told A group of convicted Insys Therapeutics Inc. executives knew when they bribed doctors to prescribe opioids that some of the powerful drugs would go to people who didn't need them, federal pros

Page: EFTA00019090 →

EFTA00032454 - EFTA00032458

1 mention

e a dispute over $2.3 million in legal fees. Read full article » SECURITIES & WHITE COLLAR Insys Investors Seek Cert. In Fentanyl Stock Drop Suit Insys Therapeutics Inc. investors urged a New York federal judge Friday to certify their putative class action accusing the pharmaceutical company of overstating its opioi

Page: EFTA00032455 →

EFTA00032577 - EFTA00032580

1 mention

doctors on Tuesday assailed a U.S. Department of Justice indictment accusing them of pocketing kickbacks to prescribe a fentanyl painkiller sold by Insys Therapeutics Inc., saying there are no concrete signs of an illicit quid pro quo. Read full article » SPORTS Grassley Seeks Answers From USOC After Nassar Report S

Page: EFTA00032578 →